Posts tagged EX Bulletin
ViroCell released in the UK to make viral vectors
ViroCell released in the UK to make viral vectors

ViroCell will supply viral vectors and genetically modified cells to academic and corporate customers for translational cell and gene therapy entering clinical trials.

Read More
In the NewsFlorence BuchananCDMO, clinical trials, viral vectors, cell and gene therapies, EX Bulletin, UK CDMO, gene therapy, cell therapy, CGT, viral vector, vector design, AAV vectors, lentivirus vectors, ViroCell, John W. Hadden II, Farzin Farzaneh, Edmund Truell, Truell Conservation Foundation, King's College London